Annual Accounts Payable
$1.78 M
-$3.51 M-66.33%
December 31, 2023
Summary
- As of February 8, 2025, VAXX annual accounts payable is $1.78 million, with the most recent change of -$3.51 million (-66.33%) on December 31, 2023.
- During the last 3 years, VAXX annual accounts payable has risen by +$766.00 thousand (+75.32%).
- VAXX annual accounts payable is now -66.33% below its all-time high of $5.29 million, reached on December 31, 2022.
Performance
VAXX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.78 M
-$1.19 M-40.05%
December 31, 2023
Summary
- As of February 8, 2025, VAXX quarterly accounts payable is $1.78 million, with the most recent change of -$1.19 million (-40.05%) on December 31, 2023.
- Over the past year, VAXX quarterly accounts payable has dropped by -$3.51 million (-66.33%).
- VAXX quarterly accounts payable is now -69.69% below its all-time high of $5.88 million, reached on June 30, 2021.
Performance
VAXX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VAXX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -66.3% | -66.3% |
| 3 y3 years | +75.3% | +75.3% |
| 5 y5 years | +38.9% | - |
VAXX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.3% | at low | -66.3% | +427.5% |
| 5 y | 5-year | -66.3% | +75.3% | -69.7% | +427.5% |
| alltime | all time | -66.3% | +75.3% | -69.7% | +427.5% |
Vaxxinity Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $1.78 M(-66.3%) | $1.78 M(-40.0%) |
| Sep 2023 | - | $2.97 M(+57.1%) |
| Jun 2023 | - | $1.89 M(-37.5%) |
| Mar 2023 | - | $3.03 M(-42.8%) |
| Dec 2022 | $5.29 M | $5.29 M(+59.5%) |
| Sep 2022 | - | $3.32 M(+882.0%) |
| Jun 2022 | - | $338.00 K(-76.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.46 M(-54.3%) |
| Dec 2021 | $3.19 M(+213.9%) | - |
| Dec 2021 | - | $3.19 M(-18.3%) |
| Sep 2021 | - | $3.90 M(-33.6%) |
| Jun 2021 | - | $5.88 M(+478.4%) |
| Dec 2020 | $1.02 M(-20.8%) | - |
| Dec 2020 | - | $1.02 M |
| Dec 2019 | $1.28 M | - |
FAQ
- What is Vaxxinity annual accounts payable?
- What is the all time high annual accounts payable for Vaxxinity?
- What is Vaxxinity annual accounts payable year-on-year change?
- What is Vaxxinity quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vaxxinity?
- What is Vaxxinity quarterly accounts payable year-on-year change?
What is Vaxxinity annual accounts payable?
The current annual accounts payable of VAXX is $1.78 M
What is the all time high annual accounts payable for Vaxxinity?
Vaxxinity all-time high annual accounts payable is $5.29 M
What is Vaxxinity annual accounts payable year-on-year change?
Over the past year, VAXX annual accounts payable has changed by -$3.51 M (-66.33%)
What is Vaxxinity quarterly accounts payable?
The current quarterly accounts payable of VAXX is $1.78 M
What is the all time high quarterly accounts payable for Vaxxinity?
Vaxxinity all-time high quarterly accounts payable is $5.88 M
What is Vaxxinity quarterly accounts payable year-on-year change?
Over the past year, VAXX quarterly accounts payable has changed by -$3.51 M (-66.33%)